![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07D 213/74 | (2006.01) |
C07C 211/35 | (2006.01) | ||
A61K 31/135 | (2006.01) | ||
A61P 35/00 | (2006.01) | ||
A61P 31/12 | (2006.01) | ||
A61P 25/00 | (2006.01) |
(11) | Number of the document | 2776394 |
(13) | Kind of document | T |
(96) | European patent application number | 12787388.3 |
Date of filing the European patent application | 2012-10-22 | |
(97) | Date of publication of the European application | 2014-09-17 |
(45) | Date of publication and mention of the grant of the patent | 2018-12-26 |
(46) | Date of publication of the claims translation | 2019-04-25 |
(86) | Number | PCT/EP2012/070900 |
Date | 2012-10-22 |
(87) | Number | WO 2013/057322 |
Date | 2013-04-25 |
(30) | Number | Date | Country code |
11382324 | 2011-10-20 | EP | |
11382329 | 2011-10-27 | EP | |
201161558370 P | 2011-11-10 | US | |
201161558369 P | 2011-11-10 | US |
(72) |
ORTEGA MUŃOZ, Alberto, ES
FYFE, Matthew Colin Thor, ES
MARTINELL PEDEMONTE, Marc, ES
ESTIARTE MARTINEZ, Maria de los Angeles, ES
VALLS VIDAL, Nuria, ES
KURZ, Guido, ES
CASTRO PALOMINO LARIA, Julio Cesar, ES
|
(73) |
Oryzon Genomics, S.A.,
Carrera de San Jer nimo 15, 2nd Floor, 28014 Madrid,
ES
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | (Hetero)arilciklopropilamino junginiai, kaip LSD1 inhibitoriai |
(HETERO)ARYL CYCLOPROPYLAMINE COMPOUNDS AS LSD1 INHIBITORS |
Payment date | Validity (years) | Amount | |
2024-10-11 | 13 | 289.00 EUR |
2025-10-22 |